IN SILICO HEAD-TO-HEAD COMPARISON OF INSULIN GLARGINE 300 U/ML AND INSULIN DEGLUDEC IN TYPE 1 DIABETES

被引：0

作者：

Visentin, R. ^{[1
]}

Schiavon, M. ^{[1
]}

Giegerich, C. ^{[2
]}

Sieber, J. ^{[2
]}

Man, C. Dalla ^{[1
]}

Cobelli, C. ^{[1
]}

Klabunde, T. ^{[2
]}

机构：

[1] Univ Padua, Dept Informat Engn, Padua, Italy

[2] Sanofi Aventis Deutschland GmbH, Frankfurt, Germany

来源：

DIABETES TECHNOLOGY & THERAPEUTICS | 2018年 / 20卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

037

引用

页码：A18 / A18

页数：1

共 50 条

[41] Low Blood Glucose Index and Hypoglycaemia Risk: Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Type 2 Diabetes [J].

Boris Kovatchev ;

Zhaoling Meng ;

Anna M. G. Cali ;

Riccardo Perfetti ;

Marc D. Breton .

Diabetes Therapy, 2020, 11 :1293-1302

[42] Response to insulin degludec and insulin glargine 300 U/mL: Which of these two insulins causes less hypoglycemia? [J].

Yamabe, Mizuho .

JOURNAL OF DIABETES INVESTIGATION, 2019, 10 (06) :1597-1598

[43] COMPARATIVE COST AND SAVING ANALYSIS OF INSULIN GLARGINE-300U/ML (GLA-300) VS INSULIN DEGLUDEC 100 U/ML IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS BASED ON THE BRIGHT [J].

Safia, M. ;

Hachelaf, Z. ;

Aissaoui, A. ;

Mahieu, A. ;

Abdul, Jabbar O. A. .

VALUE IN HEALTH, 2024, 27 (12) :S123-S123

[44] Insulin glargine 300 U/ml for the treatment of feline diabetes mellitus [J].

Linari, Guido ;

Fleeman, Linda ;

Gilor, Chen ;

Giacomelli, Lucia ;

Fracassi, Federico .

JOURNAL OF FELINE MEDICINE AND SURGERY, 2022, 24 (02) :168-176

[45] Glycaemic control and hypoglycaemia risk with insulin glargine 300 U/mL and insulin degludec 100 U/mL in older participants in the BRIGHT trial [J].

Bolli, Geremia B. ;

Cheng, Alice ;

Charbonnel, Bernard ;

Aroda, Vanita R. ;

Westerbacka, Jukka ;

Bosnyak, Zsolt ;

Boelle-Le Corfec, Emmanuelle ;

Rosenstock, Julio .

DIABETES OBESITY & METABOLISM, 2021, 23 (07) :1588-1593

[46] Similar glycaemic control and less or comparable hypoglycaemia with insulin glargine 300 U/ml vs degludec 100 U/ml in insulin naive type 2 diabetes: the BRIGHT randomised study [J].

Cheng, A. ;

Rosenstock, J. ;

Ritzel, R. ;

Bosnyak, Z. ;

Devisme, C. ;

Stella, P. ;

Cali, A. M. G. ;

Wang, X. ;

Frias, J. ;

Roussel, R. ;

Bolli, G. B. .

DIABETOLOGIA, 2018, 61 :S42-S42

[47] Lower hypoglycemia rates with Glargine 300 U/mL vs. insulin Degludec 100 U/mL in insulin-naive adults with type 2 diabetes - The BRIGHT Randomized Study [J].

Bolli, Geremia ;

Scherer, Thomas ;

Cheng, Alice ;

Bosnyak, Zsolt ;

Boelle-Le Corfec, Emmanuelle ;

Cali, Anna ;

Wang, Xiangling ;

Frias, Juan ;

Roussel, Ronan ;

Rosenstock, Julio .

WIENER KLINISCHE WOCHENSCHRIFT, 2018, 130 :369-369

[48] Comparison of insulin glargine 300 U/mL and insulin degludec using flash glucose monitoring: A randomized cross-over study [J].

Yamabe, Mizuho ;

Kuroda, Mami ;

Hirosawa, Yasuyo ;

Kamino, Hiromi ;

Ohno, Haruya ;

Yoneda, Masayasu .

JOURNAL OF DIABETES INVESTIGATION, 2019, 10 (02) :352-357

[49] A Comparison of Insulin Glargine U300 and Insulin Degludec around Spontaneous Exercise Sessions in People with Type 1 Diabetes-The ULTRAFLEXI-1 Study [J].

Moser, Othmar ;

Mueller, Alexander ;

Aberer, Felix ;

Aziz, Faisal ;

Kojzar, Harald ;

Sourij, Caren ;

Obermayer, Anna M. ;

Abbas, Farah M. ;

Birnbaumer, Philipp ;

Eckstein, Max L. ;

Honger, Lukas ;

Lenz, Jacqueline ;

Mursic, Ines ;

Sternad, Christoph ;

Zanker, Matthias ;

Ziko, Haris ;

Pferschy, Peter N. ;

Tripolt, Norbert J. ;

Sourij, Harald .

DIABETES, 2022, 71

[50] Effectiveness and Safety of Insulin Glargine 300 U/ml in Comparison with Insulin Degludec 100 U/ml Evaluated with Continuous Glucose Monitoring in Adults with Type 1 Diabetes and Suboptimal Glycemic Control in Routine Clinical Practice: The OneCARE Study [J].

Ignacio Conget ;

Miguel Ángel Mangas ;

Cristóbal Morales ;

Juan Caro ;

Margarita Giménez ;

Mireia Borrell ;

Elías Delgado .

Diabetes Therapy, 2021, 12 :2993-3009

← 1 2 3 4 5 →